Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. (Q43216549)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

1 reference

Liberato Aldo Ferrara

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Teodoro Marotta

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Barbara F Russo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

1 reference

17 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

1608-1613

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Metabolic complications of obesity in childhood and adolescence: more than just diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Improvement of cardiovascular risk profile in an elderly population of low social level: the ICON (Improving Cardiovascular risk profile in Older Neapolitans) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Fractional esterification rate of HDL particles in patients with type 2 diabetes. Relation to coronary heart disease risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Fractional esterification rate of cholesterol in high density lipoprotein (HDL) can predict the particle size of low density lipoprotein and HDL in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Uric acid and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

Comment on the provisional report from the WHO consultation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.446

31 March 2020

Identifiers

DOI

10.1038/OBY.2009.446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20019684%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference